AURA - Aura Biosciences, Inc.
5.47
-0.450 -8.227%
Share volume: 293,550
Last Updated: 05-06-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$5.92
-0.45
-0.08%
View ratios
Fiscal Date | 12-31-2024 | |
---|---|---|
Fiscal Quarter | Q4 2024 | |
Report Date | 03-24-2025 | |
Total revenue | 0.000 | |
Cost of revenue | 0.000 | |
Gross profit | 0.000 | |
Operating expenses | 27.809 M | |
Selling general and admin | 5.474 M | |
Research and development | 22.335 M | |
Total expenses | 27.809 M | |
Operating income | -27.809 M | |
Ebit | -27.846 M | |
Pretax income | -25.811 M | |
Income tax | 23.000 K | |
Net income basic | 0.000 | |
Net income | -25.834 M | |